|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Leemans CR, Braakhuis BJ and Brakenhoff
RH: The molecular biology of head and neck cancer. Nat Rev Cancer.
11:9–22. 2011. View
Article : Google Scholar
|
|
4
|
Argiris A, Karamouzis MV, Raben D and
Ferris RL: Head and neck cancer. Lancet. 371:1695–1709. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tamagawa S, Beder LB, Hotomi M, Gunduz M,
Yata K, Grenman R and Yamanaka N: Role of miR-200c/miR-141 in the
regulation of epithelial-mesenchymal transition and migration in
head and neck squamous cell carcinoma. Int J Mol Med. 33:879–886.
2014.PubMed/NCBI
|
|
6
|
Wang T, Chen T, Niu H, Li C, Xu C, Li Y,
Huang R, Zhao J and Wu S: MicroRNA-218 inhibits the proliferation
and metastasis of esophageal squamous cell carcinoma cells by
targeting BMI1. Int J Mol Med. 36:93–102. 2015.PubMed/NCBI
|
|
7
|
Zhang YY, Lu L, Abliz G and Mijit F: Serum
carotenoid, retinol and tocopherol concentrations and risk of
cervical cancer among chinese women. Asian Pac J Cancer Prev.
16:2981–2986. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ansari MS and Sgupta NP: A comparison of
lycopene and orchidectomy vs orchidectomy alone in the management
of advanced prostate cancer. BJU Int. 95:4532005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gharib A and Faezizadeh Z: In vitro
anti-telomerase activity of novel lycopene-loaded nanospheres in
the human leukemia cell line K562. Pharmacogn Mag. 10(Suppl 1):
S157–S163. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ford NA, Elsen AC, Zuniga K, Lindshield BL
and Erdman JW Jr: Lycopene and apo-12′-lycopenal reduce cell
proliferation and alter cell cycle progression in human prostate
cancer cells. Nutr Cancer. 63:256–263. 2011. View Article : Google Scholar
|
|
11
|
Takeshima M, Ono M, Higuchi T, Chen C,
Hara T and Nakano S: Anti-proliferative and apoptosis-inducing
activity of lycopene against three subtypes of human breast cancer
cell lines. Cancer Sci. 105:252–257. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tang FY, Pai MH and Wang XD: Consumption
of lycopene inhibits the growth and progression of colon cancer in
a mouse xenograft model. J Agric Food Chem. 59:9011–9021. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Palozza P, Simone RE, Catalano A and Mele
MC: Tomato lycopene and lung cancer prevention: From experimental
to human studies. Cancers (Basel). 3:2333–2357. 2011. View Article : Google Scholar
|
|
14
|
Holzapfel NP, Holzapfel BM, Champ S,
Feldthusen J, Clements J and Hutmacher DW: The potential role of
lycopene for the prevention and therapy of prostate cancer: From
molecular mechanisms to clinical evidence. Int J Mol Sci.
14:14620–14646. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Goldar S, Khaniani MS, Derakhshan SM and
Baradaran B: Molecular mechanisms of apoptosis and roles in cancer
development and treatment. Asian Pac J Cancer Prev. 16:2129–2144.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wheeler SE, Suzuki S, Thomas SM, Sen M,
Leeman-Neill RJ, Chiosea SI, Kuan CT, Bigner DD, Gooding WE, Lai SY
and Grandis JR: Epidermal growth factor receptor variant III
mediates head and neck cancer cell invasion via STAT3 activation.
Oncogene. 29:5135–5145. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zuo T, Liu TM, Lan X, Weng YI, Shen R, Gu
F, Huang YW, Liyanarachchi S, Deatherage DE, Hsu PY, et al:
Epigenetic silencing mediated through activated PI3K/AKT signaling
in breast cancer. Cancer Res. 71:1752–1762. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
da Silva HB, Amaral EP, Nolasco EL, de
Victo NC, Atique R, Jank CC, Anschau V, Zerbini LF and Correa RG:
Dissecting major signaling pathways throughout the development of
prostate cancer. Prostate Cancer. 2013:9206122013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shi L, Wang L, Wang B, Cretoiu SM, Wang Q,
Wang X and Chen C: Regulatory mechanisms of betacellulin in CXCL8
production from lung cancer cells. J Transl Med. 12:702014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Manning BD and Cantley LC: AKT/PKB
signaling: Navigating downstream. Cell. 129:1261–1274. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Giovannucci E, Ascherio A, Rimm EB,
Stampfer MJ, Colditz GA and Willett WC: Intake of carotenoids and
retinol in relation to risk of prostate cancer. J Natl Cancer Inst.
87:1767–1776. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wertz K: Lycopene effects contributing to
prostate health. Nutr Cancer. 61:775–783. 2009. View Article : Google Scholar
|
|
24
|
Aras A, Khokhar AR, Qureshi MZ, Silva MF,
Sobczak-Kupiec A, Pineda EA, Hechenleitner AA and Farooqi AA:
Targeting cancer with nano-bullets: Curcumin, EGCG, resveratrol and
quercetin on flying carpets. Asian Pac J Cancer Prev. 15:3865–3871.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chan CM, Fang JY, Lin HH, Yang CY and Hung
CF: Lycopene inhibits PDGF-BB-induced retinal pigment epithelial
cell migration by suppression of PI3K/Akt and MAPK pathways.
Biochem Biophys Res Commun. 388:172–176. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Elgass S, Cooper A and Chopra M: Lycopene
treatment of prostate cancer cell lines inhibits adhesion and
migration properties of the cells. Int J Med Sci. 11:948–954. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Huang CS, Shih MK, Chuang CH and Hu ML:
Lycopene inhibits cell migration and invasion and upregulates
Nm23-H1 in a highly invasive hepatocarcinoma, SK-Hep-1 cells. J
Nutr. 135:2119–2123. 2005.PubMed/NCBI
|
